A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study
- PMID: 22964741
- PMCID: PMC5665168
- DOI: 10.1097/SLA.0b013e31826cbbbd
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study
Abstract
Objective: To demonstrate that expectant observation of young infants with small adrenal masses would result in excellent event-free and overall survival.
Background: Neuroblastoma is the most common malignant tumor in infants, and in young infants, 90% of neuroblastomas are located in the adrenal gland. Although surgical resection is standard therapy, multiple observations suggest that expectant observation could be a safe alternative for infants younger than 6 months who have small adrenal masses.
Methods: A prospective study of infants younger than 6 months with small adrenal masses and no evidence of spreading beyond the primary tumor was performed at participating Children's Oncology Group institutions. Parents could choose observation or immediate surgical resection. Serial abdominal sonograms and urinary vanillylmandelic acid and homovanillic acid measurements were performed during a 90-week interval. Infants experiencing a 50% increase in the volume of the mass, urine catecholamine values, or an increase in the homovanillic acid to vanillylmandelic acid ratio greater than 2, were referred for surgical resection.
Results: Eighty-seven eligible patients were enrolled: 83 elected observation and 4 chose immediate surgery. Sixteen observational patients ultimately had surgery; 8 had International Neuroblastoma Staging System stage 1 neuroblastoma, 2 had higher staged neuroblastoma (2B and 4S), 2 had low-grade adrenocortical neoplasm, 2 had adrenal hemorrhage, and 2 had extralobar pulmonary sequestration. The 2 patients with adrenocortical tumors were resected because of a more than 50% increase in tumor volume. The 3-year event-free survival for a neuroblastoma event was 97.7 ± 2.2% within the entire cohort of patients (n = 87). The 3-year overall survival was 100%, with a median follow-up of 3.2 years. Eighty-one percent of patients on the observation arm were spared resection.
Conclusions: Expectant observation of infants younger than 6 months with small adrenal masses led to excellent event-free survival and overall survival while avoiding surgical intervention in a large majority of the patients.
Trial registration: ClinicalTrials.gov NCT00445718.
Figures
Similar articles
-
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.J Clin Oncol. 2000 Feb;18(3):477-86. doi: 10.1200/JCO.2000.18.3.477. J Clin Oncol. 2000. PMID: 10653863 Clinical Trial.
-
Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.Pediatr Surg Int. 2004 Jan;20(1):27-32. doi: 10.1007/s00383-003-1070-x. Epub 2003 Dec 19. Pediatr Surg Int. 2004. PMID: 14689211
-
Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?J Clin Oncol. 1996 May;14(5):1537-44. doi: 10.1200/JCO.1996.14.5.1537. J Clin Oncol. 1996. PMID: 8622069 Clinical Trial.
-
Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.Cochrane Database Syst Rev. 2017 Aug 25;8(8):CD010685. doi: 10.1002/14651858.CD010685.pub3. Cochrane Database Syst Rev. 2017. PMID: 28840597 Free PMC article. Review.
-
Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.Cochrane Database Syst Rev. 2015 Jan 29;1:CD010685. doi: 10.1002/14651858.CD010685.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Aug 25;8:CD010685. doi: 10.1002/14651858.CD010685.pub3. PMID: 25634649 Updated. Review.
Cited by
-
Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China.World J Pediatr. 2019 Apr;15(2):148-152. doi: 10.1007/s12519-018-0205-z. Epub 2018 Nov 16. World J Pediatr. 2019. PMID: 30446974
-
Neuroblastoma: molecular pathogenesis and therapy.Annu Rev Med. 2015;66:49-63. doi: 10.1146/annurev-med-011514-023121. Epub 2014 Oct 27. Annu Rev Med. 2015. PMID: 25386934 Free PMC article. Review.
-
Mechanisms of neuroblastoma regression.Nat Rev Clin Oncol. 2014 Dec;11(12):704-13. doi: 10.1038/nrclinonc.2014.168. Epub 2014 Oct 21. Nat Rev Clin Oncol. 2014. PMID: 25331179 Free PMC article. Review.
-
Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients.Transl Pediatr. 2023 Nov 28;12(11):1926-1930. doi: 10.21037/tp-23-391. Epub 2023 Nov 23. Transl Pediatr. 2023. PMID: 38130585 Free PMC article. No abstract available.
-
Prenatal presentation of an adrenocortical tumor.Cancer Rep (Hoboken). 2022 Oct;5(10):e1670. doi: 10.1002/cnr2.1670. Epub 2022 Sep 2. Cancer Rep (Hoboken). 2022. PMID: 36052764 Free PMC article.
References
-
- Gutierrez JC, Fischer AC, Sola JE, et al. Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients. Pediatr Surg Int. 2007;23:637–646. - PubMed
-
- Nitschke R, Smith EI, Shochat S, et al. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol. 1988;6:1271–1279. - PubMed
-
- De BB, Conte M, Mancini A, et al. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol. 1995;13:884–893. - PubMed
-
- Evans AE, Silber JH, Shpilsky A, et al. Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution. J Clin Oncol. 1996;14:2504–2510. - PubMed
-
- Ikeda H, Suzuki N, Takahashi A, et al. Surgical treatment of neuroblastomas in infants under 12 months of age. J Pediatr Surg. 1998;33:1246–1250. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical